Precision Epigenomics
- CMO, CRO
- Diagnostics
- Institute, hospital research
- Medical device or technology
- Other R&D services
Precision Epigenomics Inc is a molecular diagnositc company in the oncology space. We feature liquid biopsy tests for early cancer detection. Our EPISEEK multi cancer detection test (MCED) is currently commercially available as a laboratory developed test in our CLIA certified laboratory located in Arizona. In addition to our EPISEEK-MCED test, we are developing additional liquid biopsy test for diagnositic, response to therapy, and minimal residual disease detection markets.